Search Results

You are looking at 101 - 110 of 1,296 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Erin E. Hahn, Michael K. Gould, Corrine E. Munoz-Plaza, Janet S. Lee, Carla Parry, and Ernest Shen

adjusted for multiple pairwise comparisons between comorbidity classes by using the Bonferroni correction. Table 1. Patient Characteristics, Cancer Treatment, and Comorbidities Results We identified 7,803 patients with CRC ( Table 1

Full access

Ishveen Chopra, Malcolm D. Mattes, Patricia Findley, Xi Tan, Nilanjana Dwibedi, and Usha Sambamoorthi

service. Each individual was observed for 48 months ( Figure 1 ). Figure 1. Schematic of the study design. Each individual was observed for 48 months with a 24-month baseline (for identification of CAD and baseline characteristics), 12-month preindex, and

Full access

Carrie Zornosa, Jonathan L. Vandergrift, Gregory P. Kalemkerian, David S. Ettinger, Michael S. Rabin, Mary Reid, Gregory A. Otterson, Marianna Koczywas, Thomas A. D'Amico, Joyce C. Niland, Rizvan Mamet, and Katherine M. Pisters

Member Institution. Data collection includes patient, disease, and treatment characteristics that are manually abstracted from medical records by trained data managers at each participating site. Data are abstracted for each patient in 6-month intervals

Full access

Daphna Y. Spiegel, Matthew J. Boyer, Julian C. Hong, Christina D. Williams, Michael J. Kelley, Joseph K. Salama, and Manisha Palta

resection and consideration of adjuvant chemotherapy (AC) based on patient and tumor characteristics. The role of AC in colon cancer is supported by the results of NSABP C01, 1 a pooled analysis, 2 and the MOSAIC trial 3 showing improvement in disease

Full access

Seanthel Delos Santos, Noah Witzke, Bishal Gyawali, Vanessa Sarah Arciero, Amanda Putri Rahmadian, Louis Everest, Matthew C. Cheung, and Kelvin K. Chan

assessed at the time of primary publication and at 3 years post-FDA approval using all publicly available data in eligible subsequent publications. Results Characteristics of Included Studies Of 113 indications that met the eligibility criteria, there were

Full access

Ritesh R. Kotecha, Ronan Flippot, Taylor Nortman, Annalisa Guida, Sujata Patil, Bernard Escudier, Robert J. Motzer, Laurence Albiges, and Martin H. Voss

clinical variables. R version 3.6.1 (R Foundation for Statistical Computing) was used for statistical analyses. Results Patient Characteristics From 2001 through 2019, 68 clinical trials conducted at Gustave Roussy and Memorial Sloan Kettering

Full access

Ashish Rai, Xuesong Han, Zhiyuan Zheng, K. Robin Yabroff, and Ahmedin Jemal

characteristics (year 1 sociodemographic features, insurance status, usual source of care, comorbidity count, smoking status, active treatment status, tertile of office visits, any ED visits, and any inpatient care) and membership of the highest satisfaction

Full access

Pamala A. Pawloski, Gabriel A. Brooks, Matthew E. Nielsen, and Barbara A. Olson-Bullis

Background Clinical decision support (CDS) systems include any electronic system designed to directly aid clinical decision-making by using individual patient characteristics to generate patient-specific assessments or recommendations. 1 , 2 These

Full access

Erwei Zeng, Wei He, Karin E. Smedby, and Kamila Czene

Sweden, collecting detailed information on tumor characteristics and treatments. 15 , 16 The Swedish Prescribed Drug Register (SPDR) is a nationwide database that records all dispensed prescription drugs in pharmacies since July 2005, with <0.3% of data

Full access

Erwei Zeng, Wei He, Karin E. Smedby, and Kamila Czene

, collecting detailed information on tumor characteristics and treatments. 15 , 16 The Swedish Prescribed Drug Register (SPDR) is a nationwide database that records all dispensed prescription drugs in pharmacies since July 2005, with <0.3% of data missing. 17